Related Experiment Video

Updated: Aug 17, 2026

An Injectable and Drug-loaded Supramolecular Hydrogel for Local Catheter Injection into the Pig Heart
10:28

An Injectable and Drug-loaded Supramolecular Hydrogel for Local Catheter Injection into the Pig Heart

Published on: June 7, 2015

Using hydrogel polymers for drug delivery

A M McNair1

  • 1Biocompatibles Ltd., Farnbam, UK.

Medical Device Technology
|November 3, 1996
PubMed

Insights

Cardiovascular disease is a major health concern. A new phosphorylcholine coating for coronary stents may reduce thrombosis and allow targeted drug delivery, minimizing systemic side effects.

Area of Science:

  • Biomaterials Science
  • Cardiovascular Medicine
  • Drug Delivery Systems

Background:

  • Cardiovascular disease is a leading cause of death globally.
  • Coronary stenting improves outcomes for coronary artery disease but risks thrombosis.
  • Systemic drug delivery for cardiovascular conditions can cause adverse effects.

Purpose of the Study:

  • To evaluate a novel phosphorylcholine coating for coronary stents.
  • To assess the coating's nonthrombogenic properties.
  • To investigate its potential for localized drug incorporation and delivery.

Main Methods:

  • Evaluation of a phosphorylcholine-based coating material.
  • Assessment of thrombogenicity in a relevant model (details not specified in abstract).
  • Analysis of drug incorporation and release capabilities (details not specified in abstract).

Main Results:

  • The phosphorylcholine coating demonstrated nonthrombogenic characteristics.
  • The coating has the potential to incorporate and deliver drugs locally.
  • This approach may reduce systemic toxicity associated with current treatments.

Conclusions:

  • Phosphorylcholine coatings represent a promising advancement for coronary stents.
  • This technology could mitigate thrombosis risks and improve drug delivery efficacy.
  • Further research may lead to safer and more effective cardiovascular interventions.

More Related Videos

The Synthesis of RGD-functionalized Hydrogels as a Tool for Therapeutic Applications09:30

The Synthesis of RGD-functionalized Hydrogels as a Tool for Therapeutic Applications

Published on: October 7, 2016

Injectable Supramolecular Polymer-Nanoparticle Hydrogels for Cell and Drug Delivery Applications09:39

Injectable Supramolecular Polymer-Nanoparticle Hydrogels for Cell and Drug Delivery Applications

Published on: February 7, 2021

Related Concept Videos

Modified-Release Drug Delivery Systems: Rate-Programmed II01:19

Modified-Release Drug Delivery Systems: Rate-Programmed II

Rate-programmed drug delivery systems release drugs in a controlled manner to maintain therapeutic levels. Three main designs include reservoir, matrix, and hybrid systems.Reservoir systems consist of a drug core enclosed within a membrane that controls drug release. In non-swelling reservoir systems, polymers like ethyl cellulose or polymethacrylates are used. These do not hydrate in aqueous media and control release through membrane thickness, porosity, or insolubility. This type includes...
Modified-Release Drug Delivery Systems: Stimuli-Activated01:30

Modified-Release Drug Delivery Systems: Stimuli-Activated

Stimuli-activated drug delivery systems are designed to release drugs in response to specific physical, chemical, or biological stimuli. These systems often utilize hydrogels—three-dimensional, hydrophilic polymer networks capable of swelling in aqueous environments and retaining significant fluid volumes. Upon exposure to particular stimuli, these hydrogels undergo structural transitions that allow the embedded drug to be released. Due to this adaptive behavior, such systems are also called...
Site-Targeted Drug Delivery Systems: Polymeric Carriers01:24

Site-Targeted Drug Delivery Systems: Polymeric Carriers

Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...